GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
253 hedge funds and large institutions have $4.09B invested in Global Blood Therapeutics, Inc. in 2020 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 77 increasing their positions, 81 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
5% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 81
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
253
Holding in Top 10
5
Calls
$48.5M
Puts
$40.4M
Top Buyers
| 1 | +$48.8M | |
| 2 | +$45.2M | |
| 3 | +$34.2M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$28.4M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$22M |
Top Sellers
| 1 | -$74.3M | |
| 2 | -$39M | |
| 3 | -$36.8M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$31.1M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$27.5M |